Vor Biopharma

VOR • NASDAQ • Stock Fundamentals

Vor Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jean-Paul Kress, with a market cap of $776.5M.

Market Cap$776.5M

Employees168.0

CEOJean-Paul Kress

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Vor Biopharma

Vor Biopharma (VOR) has a market capitalization of $776.5M and trades on NASDAQ.

Vor Biopharma has approximately 168 employees.